• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For February 27, 2023

    2/27/23 7:46:14 AM ET
    $AAON
    $ACAD
    $ACHC
    $ADUS
    Industrial Machinery/Components
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAON alert in real time by email

    Companies Reporting Before The Bell

    • Kosmos Energy (NYSE:KOS) is projected to report quarterly earnings at $0.14 per share on revenue of $505.61 million.

    • Alcon (NYSE:ALC) is expected to report quarterly earnings at $0.88 per share on revenue of $205.25 million.

    • Itron (NASDAQ:ITRI) is estimated to report quarterly earnings at $0.09 per share on revenue of $433.64 million.

    • Fisker (NYSE:FSR) is expected to report quarterly loss at $0.42 per share on revenue of $2.51 million.

    • BGC Partners (NASDAQ:BGCP) is likely to report quarterly earnings at $0.16 per share on revenue of $422.99 million.

    • Tegna (NYSE:TGNA) is likely to report quarterly earnings at $1.13 per share on revenue of $963.23 million.

    • Nordic American Tankers (NYSE:NAT) is likely to report quarterly earnings at $0.19 per share on revenue of $73.67 million.

    • Harsco (NYSE:HSC) is estimated to report quarterly loss at $0.07 per share on revenue of $460.05 million.

    • Protalix BioTherapeutics (AMEX:PLX) is likely to report quarterly loss at $0.15 per share on revenue of $6.12 million.

    • Viatris (NASDAQ:VTRS) is estimated to report quarterly earnings at $0.72 per share on revenue of $3.98 billion.

    • FREYR Battery (NYSE:FREY) is likely to report earnings for its fourth quarter.

    • Li Auto (NASDAQ:LI) is projected to report quarterly earnings at $0.02 per share on revenue of $2.55 billion.

    • QuantaSing Group (NASDAQ:QSG) is likely to report earnings for its second quarter.

    • Lincoln Educational Servs (NASDAQ:LINC) is estimated to report quarterly earnings at $0.26 per share on revenue of $89.69 million.

    • Ready Capital (NYSE:RC) is likely to report quarterly earnings at $0.42 per share on revenue of $78.37 million.

    • FuboTV (NYSE:FUBO) is projected to report quarterly loss at $0.71 per share on revenue of $285.54 million.

    • Freshpet (NASDAQ:FRPT) is estimated to report quarterly loss at $0.09 per share on revenue of $152.11 million.

    • Global Partners (NYSE:GLP) is likely to report quarterly earnings at $1.40 per share on revenue of $4.51 billion.

    • Compugen (NASDAQ:CGEN) is projected to report earnings for its fourth quarter.

    • Opera (NASDAQ:OPRA) is likely to report quarterly earnings at $0.17 per share on revenue of $90.24 million.

    • LendingTree (NASDAQ:TREE) is likely to report quarterly loss at $0.34 per share on revenue of $208.14 million.

    • Pinnacle West Capital (NYSE:PNW) is projected to report quarterly loss at $0.18 per share on revenue of $638.28 million.

    • Axsome Therapeutics (NASDAQ:AXSM) is likely to report quarterly loss at $1.14 per share on revenue of $21.89 million.

    • Blackstone Secured (NYSE:BXSL) is estimated to report quarterly earnings at $0.88 per share on revenue of $246.76 million.

    • AES (NYSE:AES) is projected to report quarterly earnings at $0.46 per share on revenue of $2.99 billion.

    • Koppers Hldgs (NYSE:KOP) is likely to report quarterly earnings at $0.92 per share on revenue of $506.50 million.

    • Global Blue Gr Holding (NYSE:GB) is projected to report earnings for its third quarter.

    • Essential Utilities (NYSE:WTRG) is estimated to report quarterly earnings at $0.45 per share on revenue of $573.22 million.

    Companies Reporting After The Bell

    • Ovintiv (NYSE:OVV) is likely to report quarterly earnings at $2.58 per share on revenue of $3.45 billion.

    • Range Resources (NYSE:RRC) is estimated to report quarterly earnings at $1.18 per share on revenue of $973.55 million.

    • RLJ Lodging (NYSE:RLJ) is likely to report quarterly earnings at $0.00 per share on revenue of $304.05 million.

    • Ingevity (NYSE:NGVT) is estimated to report quarterly earnings at $0.87 per share on revenue of $392.90 million.

    • Heico (NYSE:HEI) is expected to report quarterly earnings at $0.69 per share on revenue of $588.75 million.

    • Hims & Hers Health (NYSE:HIMS) is likely to report quarterly loss at $0.07 per share on revenue of $161.17 million.

    • ONEOK (NYSE:OKE) is expected to report quarterly earnings at $1.03 per share on revenue of $6.03 billion.

    • Occidental Petroleum (NYSE:OXY) is expected to report quarterly earnings at $1.80 per share on revenue of $8.66 billion.

    • Theravance Biopharma (NASDAQ:TBPH) is estimated to report quarterly loss at $0.17 per share on revenue of $15.72 million.

    • Argo Gr Intl Hldgs (NYSE:ARGO) is likely to report quarterly loss at $1.75 per share on revenue of $469.95 million.

    • ACADIA Pharmaceuticals (NASDAQ:ACAD) is estimated to report quarterly loss at $0.24 per share on revenue of $134.07 million.

    • Vimeo (NASDAQ:VMEO) is expected to report quarterly loss at $0.15 per share on revenue of $105.00 million.

    • Inari Medical (NASDAQ:NARI) is projected to report quarterly loss at $0.17 per share on revenue of $104.84 million.

    • Biomarin Pharmaceutical (NASDAQ:BMRN) is expected to report quarterly loss at $0.07 per share on revenue of $536.97 million.

    • CareDx (NASDAQ:CDNA) is expected to report quarterly loss at $0.09 per share on revenue of $81.66 million.

    • Vaxcyte (NASDAQ:PCVX) is projected to report earnings for its fourth quarter.

    • ARKO (NASDAQ:ARKO) is estimated to report quarterly earnings at $0.09 per share on revenue of $2.21 billion.

    • Innovative Ind Props (NYSE:IIPR) is estimated to report earnings for its fourth quarter.

    • NewtekOne (NASDAQ:NEWT) is likely to report quarterly earnings at $0.63 per share on revenue of $24.77 million.

    • Diamond Offshore Drilling (NYSE:DO) is estimated to report quarterly loss at $0.32 per share on revenue of $211.00 million.

    • Emergent BioSolutions (NYSE:EBS) is expected to report quarterly earnings at $0.04 per share on revenue of $296.62 million.

    • National Storage (NYSE:NSA) is projected to report earnings for its fourth quarter.

    • Kinetik Holdings (NYSE:KNTK) is likely to report quarterly earnings at $0.66 per share on revenue of $259.42 million.

    • Tidewater (NYSE:TDW) is projected to report quarterly earnings at $0.23 per share on revenue of $196.20 million.

    • 180 Degree Capital (NASDAQ:TURN) is expected to report earnings for its fourth quarter.

    • Woodside Energy Group (NYSE:WDS) is likely to report earnings for its Fiscal Year 2022.

    • Rover Group (NASDAQ:ROVR) is projected to report quarterly earnings at $0.00 per share on revenue of $50.15 million.

    • Revolution Medicines (NASDAQ:RVMD) is likely to report quarterly loss at $0.82 per share on revenue of $7.75 million.

    • Rayonier Adv Materials (NYSE:RYAM) is likely to report quarterly earnings at $0.04 per share on revenue of $436.36 million.

    • FibroGen (NASDAQ:FGEN) is estimated to report quarterly loss at $0.94 per share on revenue of $24.04 million.

    • Agora (NASDAQ:API) is likely to report quarterly loss at $0.14 per share on revenue of $40.00 million.

    • Hyster-Yale Materials (NYSE:HY) is expected to report quarterly loss at $0.22 per share on revenue of $892.55 million.

    • Sterling Infrastructure (NASDAQ:STRL) is likely to report quarterly earnings at $0.68 per share on revenue of $437.73 million.

    • Broadmark Realty Capital (NYSE:BRMK) is estimated to report quarterly earnings at $0.12 per share on revenue of $25.92 million.

    • Darling Ingredients (NYSE:DAR) is projected to report quarterly earnings at $1.34 per share on revenue of $1.70 billion.

    • Summit Hotel Properties (NYSE:INN) is estimated to report quarterly loss at $0.02 per share on revenue of $169.17 million.

    • Titan Intl (NYSE:TWI) is expected to report quarterly earnings at $0.44 per share on revenue of $523.30 million.

    • Universal Health Services (NYSE:UHS) is likely to report quarterly earnings at $2.96 per share on revenue of $3.40 billion.

    • Asure Software (NASDAQ:ASUR) is likely to report quarterly earnings at $0.00 per share on revenue of $23.73 million.

    • Progyny (NASDAQ:PGNY) is estimated to report quarterly earnings at $0.01 per share on revenue of $211.78 million.

    • Green Brick Partners (NYSE:GRBK) is projected to report quarterly earnings at $1.14 per share on revenue of $356.57 million.

    • TTEC Holdings (NASDAQ:TTEC) is projected to report quarterly earnings at $0.74 per share on revenue of $629.25 million.

    • PRA Group (NASDAQ:PRAA) is projected to report quarterly earnings at $0.32 per share on revenue of $219.13 million.

    • James River Gr Hldgs (NASDAQ:JRVR) is likely to report quarterly earnings at $0.52 per share on revenue of $212.47 million.

    • Ameresco (NYSE:AMRC) is estimated to report quarterly earnings at $0.39 per share on revenue of $366.59 million.

    • Heidrick & Struggles Intl (NASDAQ:HSII) is expected to report quarterly earnings at $0.63 per share on revenue of $222.05 million.

    • Workday (NASDAQ:WDAY) is estimated to report quarterly earnings at $0.91 per share on revenue of $1.63 billion.

    • Perrigo (NYSE:PRGO) is projected to report quarterly earnings at $0.69 per share on revenue of $1.19 billion.

    • Clarus (NASDAQ:CLAR) is likely to report quarterly earnings at $0.22 per share on revenue of $101.00 million.

    • TaskUs (NASDAQ:TASK) is expected to report quarterly earnings at $0.32 per share on revenue of $232.16 million.

    • Establishment Labs Hldgs (NASDAQ:ESTA) is likely to report quarterly loss at $0.68 per share on revenue of $43.27 million.

    • Primoris Services (NASDAQ:PRIM) is estimated to report quarterly earnings at $0.72 per share on revenue of $1.31 billion.

    • SI-BONE (NASDAQ:SIBN) is expected to report quarterly loss at $0.40 per share on revenue of $31.22 million.

    • Trex Co (NYSE:TREX) is likely to report quarterly earnings at $0.21 per share on revenue of $185.25 million.

    • Zoom Video Comms (NASDAQ:ZM) is expected to report quarterly earnings at $0.80 per share on revenue of $1.10 billion.

    • ViewRay (NASDAQ:VRAY) is projected to report quarterly loss at $0.16 per share on revenue of $33.89 million.

    • Acadia Healthcare Co (NASDAQ:ACHC) is estimated to report quarterly earnings at $0.75 per share on revenue of $660.42 million.

    • Addus HomeCare (NASDAQ:ADUS) is likely to report quarterly earnings at $0.95 per share on revenue of $246.15 million.

    • MKS Instruments (NASDAQ:MKSI) is expected to report quarterly earnings at $1.34 per share on revenue of $994.02 million.

    • Helios Technologies (NYSE:HLIO) is estimated to report quarterly earnings at $0.75 per share on revenue of $208.67 million.

    • ICU Medical (NASDAQ:ICUI) is expected to report quarterly earnings at $1.56 per share on revenue of $578.77 million.

    • AAON (NASDAQ:AAON) is estimated to report quarterly earnings at $0.56 per share on revenue of $240.28 million.

    • EverQuote (NASDAQ:EVER) is expected to report quarterly loss at $0.27 per share on revenue of $90.24 million.

    • Banco Latinoamericano (NYSE:BLX) is likely to report quarterly earnings at $0.65 per share on revenue of $42.20 million.

    • QuickLogic (NASDAQ:QUIK) is likely to report quarterly loss at $0.05 per share on revenue of $4.33 million.

    • FS KKR Capital (NYSE:FSK) is projected to report quarterly earnings at $0.73 per share on revenue of $431.57 million.

    • Tetra Technologies (NYSE:TTI) is expected to report quarterly earnings at $0.03 per share on revenue of $135.50 million.

    • New Mountain Finance (NASDAQ:NMFC) is estimated to report quarterly earnings at $0.35 per share on revenue of $82.64 million.

    • CrossAmerica Partners (NYSE:CAPL) is expected to report quarterly earnings at $0.17 per share on revenue of $725.28 million.

    • Carlyle Secured Lending (NASDAQ:CGBD) is projected to report quarterly earnings at $0.46 per share on revenue of $54.60 million.

    • ProAssurance (NYSE:PRA) is expected to report quarterly earnings at $0.15 per share on revenue of $220.26 million.

    • Howard Hughes (NYSE:HHC) is likely to report quarterly earnings at $0.97 per share on revenue of $442.90 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AAON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAON
    $ACAD
    $ACHC
    $ADUS

    CompanyDatePrice TargetRatingAnalyst
    Sterling Infrastructure Inc.
    $STRL
    2/12/2026$486.00Buy
    Stifel
    Trex Company Inc.
    $TREX
    2/11/2026Buy → Hold
    The Benchmark Company
    QuickLogic Corporation
    $QUIK
    2/9/2026$10.00Buy
    Lake Street
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Viatris Inc.
    $VTRS
    2/9/2026$18.00Neutral → Buy
    UBS
    Kinetik Holdings Inc.
    $KNTK
    2/6/2026$43.00Buy → Hold
    Jefferies
    Zoom Communications Inc.
    $ZM
    2/5/2026$115.00Peer Perform → Outperform
    Wolfe Research
    FuboTV Inc.
    $FUBO
    2/5/2026$3.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks

    Approval will broaden the NARCAN® Nasal Spray portfolio, and improve cost-effectiveness by increasing flexibility and distribution efficiency of this life-saving medication  GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions (NYSE:EBS) announced that the U.S. Food and Drug Administration (FDA) has approved its supplemental New Drug Application (sNDA) for new multipack configurations of over-the-counter (OTC) NARCAN® Nasal Spray. This approval expands the NARCAN® Nasal Spray product suite to include 6-count and 24-count multipack options, specifically designed to meet the needs of partners distributing higher volumes of naloxone. These new formats offer enhan

    2/12/26 6:00:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    BLADEX ANNOUNCES INCREASE IN QUARTERLY CASH DIVIDEND FOLLOWING RECORD 2025 RESULTS

    PANAMA CITY, Feb. 12, 2026 /PRNewswire/ -- Bladex announced today that its Board of Directors has approved an increase in the quarterly cash dividend to $0.6875 per share, up from $0.625 per share in the previous quarter. The dividend increase reflects the Bank's record financial performance in 2025 and underscores its continued commitment to delivering attractive shareholder returns while maintaining financial strength and flexibility.  The new quarterly dividend represents 46% of fourth-quarter 2025 net income, consistent with Bladex's disciplined and balanced capital alloca

    2/12/26 5:00:00 PM ET
    $BLX
    Commercial Banks
    Finance

    BLADEX ANNOUNCES NET PROFITS OF $56.0 MILLION OR $1.50 PER SHARE IN 4Q25 AND $226.9 MILLION OR $6.11 PER SHARE IN 2025

    PANAMA CITY, Feb. 12, 2026 /PRNewswire/ -- Bladex (NYSE:BLX, or ", the Bank", )), a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced today its results for the Fourth Quarter ("4Q25") and Full-year ("FY25") ended December 31, 2025. The consolidated financial information in this document has been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board (

    2/12/26 5:00:00 PM ET
    $BLX
    Commercial Banks
    Finance

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Mccallister Terry D bought $1,643 worth of shares (12 units at $138.00), increasing direct ownership by 0.06% to 20,552 units (SEC Form 4)

    4 - Primoris Services Corp (0001361538) (Issuer)

    1/16/26 6:05:05 PM ET
    $PRIM
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    General Partner Global Gp Llc bought $185,507 worth of Common units representing limited partner interests (4,330 units at $42.84), increasing direct ownership by 2% to 230,273 units (SEC Form 4)

    4 - GLOBAL PARTNERS LP (0001323468) (Issuer)

    12/23/25 4:57:26 PM ET
    $GLP
    Oil Refining/Marketing
    Energy

    PRESIDENT AND CEO Bashan Dror bought $101,360 worth of shares (56,000 units at $1.81), increasing direct ownership by 42% to 188,516 units (SEC Form 4)

    4 - Protalix BioTherapeutics, Inc. (0001006281) (Issuer)

    12/23/25 7:25:58 AM ET
    $PLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Stifel initiated coverage on Sterling Infrastructure with a new price target

    Stifel initiated coverage of Sterling Infrastructure with a rating of Buy and set a new price target of $486.00

    2/12/26 7:24:54 AM ET
    $STRL
    Military/Government/Technical
    Industrials

    Trex downgraded by The Benchmark Company

    The Benchmark Company downgraded Trex from Buy to Hold

    2/11/26 6:57:04 AM ET
    $TREX
    Forest Products
    Basic Materials

    Lake Street initiated coverage on QuickLogic with a new price target

    Lake Street initiated coverage of QuickLogic with a rating of Buy and set a new price target of $10.00

    2/9/26 7:54:57 AM ET
    $QUIK
    Semiconductors
    Technology

    $AAON
    $ACAD
    $ACHC
    $ADUS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-9) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 210793, Application Classification: Efficacy

    9/18/23 10:47:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NUPLAZID issued to ACADIA PHARMS INC

    Submission status for ACADIA PHARMS INC's drug NUPLAZID (SUPPL-12) with active ingredient PIMAVANSERIN TARTRATE has changed to 'Approval' on 09/15/2023. Application Category: NDA, Application Number: 207318, Application Classification: Efficacy

    9/18/23 10:40:05 AM ET
    $ACAD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    July 13, 2023 - FDA Approves First Nonprescription Daily Oral Contraceptive

    For Immediate Release: July 13, 2023 Today, the U.S. Food and Drug Administration approved Opill (norgestrel) tablet for nonprescription use to prevent pregnancy— the first daily oral contraceptive approved for use in the U.S. without a prescription. Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stor

    7/13/23 8:32:15 AM ET
    $PRGO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Raines Monica decreased direct ownership by 18% to 12,045 units (SEC Form 5)

    5 - Addus HomeCare Corp (0001468328) (Issuer)

    2/12/26 5:00:25 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care

    Chief Executive Officer & Pres Degner Dennis was granted 64,600 units of Common Stock Unvested (SEC Form 4)

    4 - RANGE RESOURCES CORP (0000315852) (Issuer)

    2/12/26 4:36:23 PM ET
    $RRC
    Oil & Gas Production
    Energy

    EVP & CFO Scucchi Mark was granted 32,024 units of Common Stock Unvested (SEC Form 4)

    4 - RANGE RESOURCES CORP (0000315852) (Issuer)

    2/12/26 4:35:28 PM ET
    $RRC
    Oil & Gas Production
    Energy

    $AAON
    $ACAD
    $ACHC
    $ADUS
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by CareDx Inc.

    SCHEDULE 13G/A - CareDx, Inc. (0001217234) (Subject)

    2/12/26 5:54:54 PM ET
    $CDNA
    Medical Specialities
    Health Care

    SEC Form 6-K filed by Banco Latinoamericano de Comercio Exterior S.A.

    6-K - FOREIGN TRADE BANK OF LATIN AMERICA, INC. (0000890541) (Filer)

    2/12/26 5:20:25 PM ET
    $BLX
    Commercial Banks
    Finance

    Titan International Inc. (DE) filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - TITAN INTERNATIONAL INC (0000899751) (Filer)

    2/12/26 5:08:26 PM ET
    $TWI
    Steel/Iron Ore
    Industrials

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Progyny Inc.

    SC 13G/A - Progyny, Inc. (0001551306) (Subject)

    12/6/24 10:11:35 AM ET
    $PGNY
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13D/A filed by Opera Limited

    SC 13D/A - Opera Ltd (0001737450) (Subject)

    12/6/24 6:15:42 AM ET
    $OPRA
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Global Blue Group Holding AG

    SC 13D/A - Global Blue Group Holding AG (0001799983) (Subject)

    12/5/24 6:24:01 AM ET
    $GB
    EDP Services
    Technology

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Leadership Updates

    Live Leadership Updates

    View All

    Compugen Announces the Appointment of Michele Holcomb, Ph.D., to its Board of Directors

    HOLON, Israel, Feb. 12, 2026 /PRNewswire/ -- Compugen Ltd. (NASDAQ:CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational drug target discovery powered by AI/ML, today announced the appointment of Michele Holcomb, Ph.D., as a new independent director, effective February 11, 2026. "On behalf of Compugen's Board of Directors, I am delighted to welcome Michele to the Board," said Anat Cohen-Dayag, Ph.D., Executive Chair, Compugen. "Michele brings more than three decades of experience spanning the biotech, pharmaceuticals and healthcare services industries. Her unique blend of strategic insights, corporate development, innovation and firsthand operation

    2/12/26 7:00:00 AM ET
    $CGEN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Trex Company Appoints Irene Tasi to Board of Directors

    Trex Company, Inc. (NYSE:TREX), the world's largest manufacturer of wood-alternative decking and railing, today announced the appointment of Irene Tasi as a new independent member of its Board of Directors, effective immediately. Ms. Tasi brings more than 25 years of leadership experience across the global industrial and building product sectors, with particular expertise in strategic development and transformation. She currently serves as Chief Transformation Officer at PPG, a global manufacturer and distributor of paints, coatings, and specialty products, where she leads enterprise-wide transformation and growth initiatives. During her tenure at PPG, Ms. Tasi has also served as Senior V

    2/9/26 4:10:00 PM ET
    $TREX
    Forest Products
    Basic Materials

    Workday Announces CEO Transition as Co-Founder Aneel Bhusri Returns to Lead the Company's Next Chapter

    Carl Eschenbach Steps Down After Leading Company Through a Period of Global Expansion and Operational Scale Company Reaffirms Fiscal 2026 Fourth Quarter and Full-Year Outlook PLEASANTON, Calif., Feb. 9, 2026 /PRNewswire/ -- Workday, Inc. (NASDAQ:WDAY), the enterprise AI platform for managing people, money, and agents, today announced that co-founder and current executive chair Aneel Bhusri is returning as chief executive officer as the company enters its next chapter, focused on leading in the rapidly evolving AI era. Carl Eschenbach is stepping down as CEO and as a member of the board after leading Workday through a period defined by global growth, an expanded industry focus, and strengthen

    2/9/26 8:30:00 AM ET
    $WDAY
    EDP Services
    Technology

    $AAON
    $ACAD
    $ACHC
    $ADUS
    Financials

    Live finance-specific insights

    View All

    BLADEX ANNOUNCES INCREASE IN QUARTERLY CASH DIVIDEND FOLLOWING RECORD 2025 RESULTS

    PANAMA CITY, Feb. 12, 2026 /PRNewswire/ -- Bladex announced today that its Board of Directors has approved an increase in the quarterly cash dividend to $0.6875 per share, up from $0.625 per share in the previous quarter. The dividend increase reflects the Bank's record financial performance in 2025 and underscores its continued commitment to delivering attractive shareholder returns while maintaining financial strength and flexibility.  The new quarterly dividend represents 46% of fourth-quarter 2025 net income, consistent with Bladex's disciplined and balanced capital alloca

    2/12/26 5:00:00 PM ET
    $BLX
    Commercial Banks
    Finance

    BLADEX ANNOUNCES NET PROFITS OF $56.0 MILLION OR $1.50 PER SHARE IN 4Q25 AND $226.9 MILLION OR $6.11 PER SHARE IN 2025

    PANAMA CITY, Feb. 12, 2026 /PRNewswire/ -- Bladex (NYSE:BLX, or ", the Bank", )), a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced today its results for the Fourth Quarter ("4Q25") and Full-year ("FY25") ended December 31, 2025. The consolidated financial information in this document has been prepared in accordance with International Financial Reporting Standards ("IFRS") as issued by the International Accounting Standards Board (

    2/12/26 5:00:00 PM ET
    $BLX
    Commercial Banks
    Finance

    Innovative Industrial Properties Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Innovative Industrial Properties, Inc. (IIP) (NYSE:IIPR) announced today it will report its fourth quarter 2025 results after the close of trading on the New York Stock Exchange on Monday, February 23, 2026. Management will host an investor conference call at 9:00 a.m. Pacific Time on Tuesday, February 24, 2026, to discuss the company's financial results and operations for the quarter. The call will be available through a live audio webcast at the Investor Relations section of the company's website at www.innovativeindustrialproperties.com, or live by calling 1-800-715-9871 (domestic) or 1-646-307-1963 (international) and asking to be joined to the Innovative Industrial Properties, Inc.

    2/12/26 4:30:00 PM ET
    $IIPR
    Real Estate
    Finance